Novo Nordisk

DiabetesDenmarkNorthern Europe

Novo Nordisk

Novo Nordisk (NOV:N) is a Denmark-headquartered healthcare company, providing treatment for diabetes.

Novo Nordisk (NOV:N) is a Denmark-headquartered healthcare company, providing treatment for diabetes.

The company also has positions within haemophilia care, growth hormone therapy and hormone replacement therapy.

In Janaury 2014 it was announced that Novo Nordisk’s profits had risen 15% with further growth expected. For 2014, Novo Nordisk expects a net financial income of around 750 million kroner.


Latest Articles

Latest News

Back to top